Status:

UNKNOWN

COVID-19 Advanced Respiratory Physiology (CARP) Study

Lead Sponsor:

NHS Greater Glasgow and Clyde

Collaborating Sponsors:

Altair Medical

Storm ID

Conditions:

Respiratory Failure

Covid19

Eligibility:

All Genders

Brief Summary

The anticipated second wave of COVID-19 cases will present healthcare system challenges, including requirement to monitor large numbers of patients for deteriorating respiratory failure. Rising respir...

Detailed Description

Altair medical has developed a pre-commercial investigational wearable (chest-worn) biosensor which can measure continuous respiratory rate and respiratory events. This sensor has been verified to hav...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Adult patients with respiratory failure of any cause requiring hospital admission, oxygen therapy and routine NEWS-2 physiology observations.
  • CARP detailed sub-study Adult patients with respiratory failure who are suitable for opportunistically acquired serial detailed physiology measurements taken alongside routine clinical care by study team.
  • CARP follow-up remote-monitoring sub-study Adult patients with respiratory failure who have provided informed consent and have a smartphone to connect to Fitbit and Lenus accounts for postdischarge wearable device data capture.

Exclusion

  • Exclusion criteria • Lack of capacity or inability to comprehend informed consent.

Key Trial Info

Start Date :

September 29 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 29 2021

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04668313

Start Date

September 29 2020

End Date

September 29 2021

Last Update

December 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NHS Greater Glasgow and Clyde

Glasgow, United Kingdom, G12 0XH